Recent Press Releases

Philadelphia Parkinson's Disease CommUNITY Rallied At Rocky Statue Launching New Public Awareness Campaign From The Parkinson's Unity Walk Organization And Teva

"CommUNITY: Carrying the PD Torch" Campaign Seeks to Empower and Provide Support for PD Patients

FRAZER, Pa.,

Merck Serono's President & CEO Belén Garijo has Been Appointed to Board of Directors of L'Oréal

DARMSTADT, Germany and PARIS, April 17, 2014 /PRNewswire/ --

Amgen Announces Webcast of 2014 First Quarter Financial Results

THOUSAND OAKS, Calif., April 17, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that it will

Thomson Reuters Names 2014 Drugs to Watch

Thomson Reuters Names 2014 Drugs to Watch Analysis points to three potential blockbusters: Sovaldi, Anoro Ellipta and Idelalisib entering market this year PHILADELPHIA, April 16, 2014 /PRNewswire/ --...

Teva Settles Patent Litigation with Pfizer on Celebrex®

Teva Settles Patent Litigation with Pfizer on Celebrex® JERUSALEM--(BUSINESS WIRE)--Apr. 17, 2014-- Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announced today that its subsidiary Teva...

Astellas Pharma US, Inc. reaches agreement with U.S. Department of Justice

Astellas Pharma US, Inc. reaches agreement with U.S. Department of Justice NORTHBROOK, Ill., April 16, 2014 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of...

Abbott Reports First-Quarter 2014 Results

- First-Quarter Ongoing EPS of $0.41, Above Previous Guidance Range of $0.34 to $0.36 (GAAP EPS from Continuing Operations of $0.22) -

ABBOTT PARK, Ill.,

Basketball Hall of Famer Nancy Lieberman Teams Up with New Nasacort® Allergy 24HR to Help Allergy Sufferers Put the Full 'Cort Press on Nasal Allergy Symptoms

April 15, 2014, 9:00 a.m. EDT Basketball Hall of Famer Nancy Lieberman Teams Up with New Nasacort® Allergy 24HR to Help Allergy Sufferers Put the Full 'Cort Press on Nasal Allergy Symptoms...

European Medicines Agency alerts EU healthcare professionals after vials of falsified Herceptin identified

European Medicines Agency alerts EU healthcare professionals after vials of falsified Herceptin identified The European Medicines Agency (EMA) has been informed that vials of the cancer medicine...

AdverseEvents' Special Report: Examining the Comparative Safety of Type 2 Diabetes Drugs

AdverseEvents' Special Report: Examining the Comparative Safety of Type 2 Diabetes Drugs Type 2 Diabetes Drugs Safety Review: Byetta Has Best Safety Profile, Nesina Shows Worst Safety Profile Type 2...

VisionCare Appoints Industry Veterans, Mark Forchette, and John Ryan of ONSET Ventures to its Board of Directors

SARATOGA, Calif., April 15, 2014 /PRNewswire/ -- VisionCare Ophthalmic Technologies, Inc., a developer of adv

GSK receives US approval for once-weekly type 2 diabetes treatment, Tanzeum™ (albiglutide)

LONDON, April 15, 2014 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the US Food a

Prosonix and Mylan Enter Into Global Licensing Agreement for Generic Versions of Inhaled Respiratory Products Flixotide(R) and Flovent(R)

Prosonix and Mylan Enter Into Global Licensing Agreement for Generic Versions of Inhaled Respiratory Products Flixotide(R) and Flovent(R) OXFORD, England and PITTSBURGH, April 15, 2014 /PRNewswire/...

Actavis Announces Agreement Related to Generess® FE Patent Challenge Litigation

Actavis Announces Agreement Related to Generess® FE Patent Challenge Litigation DUBLIN, April 15, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that it has entered into an...

Johnson & Johnson Reports 2014 First-Quarter Results

Johnson & Johnson Reports 2014 First-Quarter Results Sales of $18.1 Billion increased 3.5% Versus 2013 First Quarter; First-Quarter EPS was $1.64 Excluding Special Items, 2014...

Roche with good start in 2014

Roche with good start in 2014 Continued growth due to recently launched medicines Group sales up 5% at constant exchange rates, -1% in Swiss francs Pharma sales up 4%1 with continued growth of...

Acquisitions, Director Appointments, Collaborations, New Product Launches, and Earnings Guidance Revisions - Analyst Notes on Questcor, Regeneron, Lilly, Medtronic and Alexion

Editor Note: For more information about this release, please scroll to bottom.

NEW YORK, April 14, 2014

Abbott Announces FDA Clearance for a New Test to Help Physicians Quickly and Accurately Diagnose Diabetes

New Abbott test could help physicians diagnose people in the U.S.

American College of Endocrinology (ACE) focuses on emergency planning for people with diabetes at National Hurricane Conference

Organization to share tips from partnership with Lilly Diabetes to help people avoid disruptions in medical care during severe weather emergencies